miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism
Ying Hu(University of California, Davis), Yu‐Jui Yvonne Wan(University of California Davis Medical Center)
Cited by 43
Related Papers
Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function
|Biomarker Research|2020|58
Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex
|HepatoBiliary Surgery and Nutrition|2021|44